Dana Nadler

Title: Dana Nadler: Innovator in Genetic Engineering

Introduction

Dana Nadler is a prominent inventor based in Berkeley, CA (US). She has made significant contributions to the field of genetic engineering, particularly through her innovative work on Cas9 polypeptides. Her research has the potential to advance the capabilities of gene editing technologies.

Latest Patents

Dana Nadler holds a patent for "Variant Cas9 polypeptides comprising internal insertions." This patent describes variant Cas9 polypeptides that include an internal insertion of a heterologous polypeptide. The disclosure also provides nucleic acids that comprise nucleotide sequences encoding these variant Cas9 polypeptides. Additionally, it outlines host cells that contain either the variant Cas9 polypeptide or the nucleic acid encoding it. The methods described involve binding and/or modifying a target nucleic acid using the variant Cas9 polypeptide.

Career Highlights

Dana is affiliated with the University of California, where she continues her research and development in genetic engineering. Her work has garnered attention for its innovative approach to gene editing, which could have far-reaching implications in various fields, including medicine and biotechnology.

Collaborations

Dana has collaborated with notable colleagues such as Benjamin L. Oakes and David Frank Savage. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Dana Nadler is a trailblazer in the field of genetic engineering, with her innovative patent on variant Cas9 polypeptides showcasing her expertise and dedication. Her contributions are poised to make a significant impact on the future of gene editing technologies.